By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Mary Jane's PostMary Jane's Post
  • Tech
  • Science
  • Culture & Arts
  • Press Releases
  • More
    • About Us
    • Advertise
    • Monthly Give-Away
    • Partner With Us
  • Join UsNew
Reading: Hempsana Signs Letter of Intent to Enter Barbados and Caribbean Market
Share
0

No products in the cart.

Aa
Mary Jane's PostMary Jane's Post
Aa
  • Press Releases
  • Submit News
  • Join UsNew
Search
  • Topics
    • Business
    • Cannabis Community
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Press Releases
  • About Us
    • Guest Columnist
    • Ambassador
    • Partner With Us
Have an existing account? Sign In
Follow US
©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.
Mary Jane's Post > Press Releases > Hempsana Signs Letter of Intent to Enter Barbados and Caribbean Market
Press Releases

Hempsana Signs Letter of Intent to Enter Barbados and Caribbean Market

Business Wire
Posted Business Wire March 17, 2022
Updated 2022/03/17 at 4:41 PM
4 Min Read
SHARE

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR

DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

TORONTO–(BUSINESS WIRE)–$HMPS #CBD–Hempsana Holdings Ltd. (the “Company” or “Hempsana”) a leader in the production and refinement of cannabinoids and Cannabis 2.0 products, is pleased to announce that Hempsana has entered into a non-binding Letter of Intent (“LOI”) with Dreamdos Therapeutics Inc.(“Dreamdos”) to supply its premium medical cannabis products. Dreamdos is applying for its license to sell, distribute and import medical cannabis products in the Barbados market. Hempsana expects to ship its medical-grade cannabis products upon Dreamdos receiving its updated licensing.

300 ppi hi res Hempsana Logo Cannabis News

Under the terms of the agreement, Dreamdos will draw on Hempsana’s full suite of product manufacturing capabilities to supply Barbados and the Carribean market with a range of cannabis tincture products. Specifically, Dreamdos intends to initially launch three cannabis tinctures in the form of a balanced THC:CBD formulation as well as THC dominant and CBD dominant cannabis tinctures.

“On the backs of obtaining our medical sales license, this global partnership expands our footprint beyond the Canadian borders. The medical patient market has been an underserved consumer segment, not just here in Canada but globally, and we are delighted to be working with Dreamdos to bring high quality medical products to the medical patients in the Caribbean region,” said Randy Ko, President and CEO of Hempsana Inc.

“Dreamdos is extremely pleased to partner with Hempsana to bring quality medical products to legal markets in the Caribbean region,” said William Wells, Founder of Dreamdos Therapeutics Inc. “Dreamdos’ mission is to bring innovative health products to underserved patients throughout the Caribbean region. Outstanding partners like Hempsana ensure our mission is successful.”

About Hempsana Holdings Ltd.

The Company’s business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables. Hempsana’s Health Canada Standard Processing Licensed, and EU-GMP compliant facility provides the Company access to wholesale and retail channels in Canada and internationally. Hempsana currently offers a wide range of product formats, including topicals, tinctures, salves, vape pens which can all be fortified with major and minor cannabinoids that are all manufactured and distributed by Hempsana.

About Dreamdos Therapeutics Inc.

Operating through its Barbados hub, the company acquires and distributes medical products to wholesale and retail channels in legal markets for the Caribbean region.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian and U.S. securities laws. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify forward-looking information or statements. More particularly and without limitation, this press release contains forward looking statements and information concerning the business and operations of the Company. The forward-looking statements and information are based on certain key expectations and assumptions made by management, including expectations and assumptions concerning the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information. There can be no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. These risks and uncertainties, include, but are not limited to, general economic conditions and the state of the regulatory environment. Please refer to the Company’s public record on SEDAR at www.sedar.com for more details on the risks faced by the Company. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward- looking information for anything other than its intended purpose. Management of the Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

Additional Information
For additional information regarding Hempsana, please contact:

Randy Ko

Director and Chief Executive Officer

T: (647) 255-8849

E: [email protected]

You Might Also Like

Heritage Cannabis Reports 2021 Year-End Financial Results

Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

Houston Area Army Veteran Reclaims Life, Eliminates Opioid Use with Medical Cannabis

Heritage Cannabis Announces Corporate Update and Highlights Significant Sales Growth, Market Share and Growing Distribution

TAGGED: Business Wire
Business Wire March 17, 2022
Share this Article
Facebook Twitter Pinterest LinkedIn Reddit
Share
Business Wire
Posted by Business Wire
Follow:
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.
Previous Article Fluence Partners with Hydrofarm to Distribute LED Lighting Solution to U.S. Retailers
Next Article Cannabis Packaging Conference Keynotes to Explore “Opportunities in Cannabis Packaging” and “The State of California Cannabis” at April 2022 Event
- Advertisement -
Ad imageAd image

Stay Connected

Facebook Like
Twitter Follow
Pinterest Pin
Instagram Follow

You Might Also Like

Heritage Cannabis Reports 2021 Year-End Financial Results

May 12, 2022

Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca

May 11, 2022

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

May 11, 2022

Houston Area Army Veteran Reclaims Life, Eliminates Opioid Use with Medical Cannabis

May 11, 2022
Mary Jane's PostMary Jane's Post

©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.

  • PRIVACY
  • TERMS OF USE
  • CONTRIBUTOR AGREEMENT
  • CONTRIBUTOR GUIDELINES

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Register Lost your password?